Evidence map›Paper›PMID 42039268›Full record

ArticleActa pharmaceutica Sinica. B2026

An oral immune enhancer with excellent biocompatibility for effectively strengthening body's immunity and treating cancer.

Anqi Xie, Lei Feng, Yaping Shao, Yiqun Wan, Ying Zhang, Zheyi Liu, Haihua Ji, Hao Wan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anqi XieState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
Lei FengState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
Yaping ShaoLiaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, The First Affiliated Hospital, Dalian Medical University, Dalian 116021, China.
Yiqun WanState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
Ying ZhangState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
Zheyi LiuCAS Key Laboratory of Separation Sciences for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China.
Haihua JiState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.
Hao WanState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang 330047, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enhancing immunity offers a versatile yet effective strategy for treating or preventing diseases. Here, we obtained a new polysaccharide (AFP-80) from

Indexed as

Anoectochilus formosanus polysaccharidesBiocompatibilityGut microbiota modulationImmuno-enhancing effectLactobacillus plantarumSingle-cell coatingStructural characterizationTumor immune microenvironment

Identifiers

PMID42039268
PMCPMC13104664

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.